{"id":71071,"date":"2021-01-07T12:56:42","date_gmt":"2021-01-07T20:56:42","guid":{"rendered":"https:\/\/chemicalsafety.com\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/"},"modified":"2025-10-01T01:09:47","modified_gmt":"2025-10-01T08:09:47","slug":"lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir","status":"publish","type":"post","link":"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/","title":{"rendered":"L&rsquo;approbation am\u00e9ricaine d&rsquo;urgence \u00e9largit l&rsquo;utilisation du m\u00e9dicament COVID-19 de Gilead remdesivir"},"content":{"rendered":"<p>En ces temps difficiles, les bonnes nouvelles sont toujours les bienvenues et doivent \u00eatre partag\u00e9es. Nous sommes honor\u00e9s et fiers d&rsquo;annoncer que <a href=\"https:\/\/www.gilead.com\/\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.gilead.com\/&amp;source=gmail&amp;ust=1589368664833000&amp;usg=AFQjCNH0Z4W0TcTIcz8cyLVfBiMNo8850g\">Gilead Science<\/a>s, l&rsquo;un des clients les plus anciens et les plus importants de Chemical Safety Software, a re\u00e7u l&rsquo;approbation de la Food and Drug Administration <a href=\"https:\/\/www.fda.gov\/home\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.fda.gov\/home&amp;source=gmail&amp;ust=1589368664833000&amp;usg=AFQjCNFwe9aHO0Hf_UftX3R_lzezq9y5YA\">(FDA)<\/a> des \u00c9tats-Unis pour son traitement exp\u00e9rimental Covid-19 appel\u00e9 Remdesivir. \u00ad\u00ad<\/p>\n<p>Lors d&rsquo;une r\u00e9union dans le bureau ovale de la Maison Blanche avec le pr\u00e9sident Donald Trump, le directeur g\u00e9n\u00e9ral de Gilead, Daniel O&rsquo;Day, a qualifi\u00e9 cette d\u00e9cision de premi\u00e8re \u00e9tape importante et a d\u00e9clar\u00e9 que la soci\u00e9t\u00e9 faisait don de 1,5 million de flacons de m\u00e9dicament pour aider les patients. Le don devrait \u00eatre suffisant pour au moins 140 000 patients, selon le nombre de jours dont ils ont besoin pour \u00eatre trait\u00e9s.<\/p>\n<p>Gilead (<a href=\"https:\/\/www.google.com\/search?q=NASDQ+GILD&amp;oq=NASDQ+GILD&amp;aqs=chrome..69i57j0l7.1136j0j7&amp;sourceid=chrome&amp;ie=UTF-8\">NASDQ GILD<\/a>) a d\u00e9clar\u00e9 que le m\u00e9dicament, administr\u00e9 par perfusion intraveineuse, avait contribu\u00e9 \u00e0 am\u00e9liorer les r\u00e9sultats des patients atteints de COVID-19, la maladie respiratoire caus\u00e9e par le nouveau coronavirus, et a fourni des donn\u00e9es sugg\u00e9rant qu&rsquo;il fonctionnait mieux lorsqu&rsquo;il \u00e9tait administr\u00e9 plus t\u00f4t au cours de infection.<\/p>\n<p>Nous saluons les efforts de Gilead et nous nous joignons \u00e0 nous tous pour entendre d\u2019autres bonnes nouvelles sur cette nouvelle option de traitement.<\/p>\n<p>Sources:<\/p>\n<p><a href=\"https:\/\/www.barrons.com\/articles\/coronavirus-news-updates-51588339547\" target=\"_blank\" rel=\"noopener\">La FDA accorde une autorisation d\u2019urgence pour le m\u00e9dicament Covid-19 de Gilead<\/a><br \/>\n<a href=\"https:\/\/www.reuters.com\/article\/health-coronavirus-usa-fda\/us-emergency-approval-broadens-use-of-gileads-covid-19-drug-remdesivir-idUSL1N2CM0ZH\" target=\"_blank\" rel=\"noopener\">L&rsquo;approbation am\u00e9ricaine d&rsquo;urgence \u00e9largit l&rsquo;utilisation du m\u00e9dicament COVID-19 de Gilead remdesivir<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>En ces temps difficiles, les bonnes nouvelles sont toujours les bienvenues et doivent \u00eatre partag\u00e9es. Nous sommes honor\u00e9s et fiers d&rsquo;annoncer que Gilead Sciences, l&rsquo;un des clients les plus anciens et les plus importants de Chemical Safety Software, a re\u00e7u l&rsquo;approbation de la Food and Drug Administration (FDA) des \u00c9tats-Unis pour son traitement exp\u00e9rimental Covid-19 [&hellip;]<\/p>\n","protected":false},"author":3590,"featured_media":89592,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[195],"tags":[],"class_list":["post-71071","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.0 (Yoast SEO v26.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L&#039;approbation am\u00e9ricaine d&#039;urgence \u00e9largit l&#039;utilisation du m\u00e9dicament COVID-19 de Gilead remdesivir<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L&#039;approbation am\u00e9ricaine d&#039;urgence \u00e9largit l&#039;utilisation du m\u00e9dicament COVID-19 de Gilead remdesivir\" \/>\n<meta property=\"og:description\" content=\"En ces temps difficiles, les bonnes nouvelles sont toujours les bienvenues et doivent \u00eatre partag\u00e9es. Nous sommes honor\u00e9s et fiers d&rsquo;annoncer que Gilead Sciences, l&rsquo;un des clients les plus anciens et les plus importants de Chemical Safety Software, a re\u00e7u l&rsquo;approbation de la Food and Drug Administration (FDA) des \u00c9tats-Unis pour son traitement exp\u00e9rimental Covid-19 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/\" \/>\n<meta property=\"og:site_name\" content=\"ChemicalSafety\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Chemical-Safety-Software-1391503304442241\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-07T20:56:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-01T08:09:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"750\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Chemical Safety Software\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@chemsafeems\" \/>\n<meta name=\"twitter:site\" content=\"@chemsafeems\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Chemical Safety Software\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/\"},\"author\":{\"name\":\"Chemical Safety Software\",\"@id\":\"https:\/\/chemicalsafety.com\/fr\/#\/schema\/person\/9a6af7129d32d51cd09d6bbfbcb03336\"},\"headline\":\"L&rsquo;approbation am\u00e9ricaine d&rsquo;urgence \u00e9largit l&rsquo;utilisation du m\u00e9dicament COVID-19 de Gilead remdesivir\",\"datePublished\":\"2021-01-07T20:56:42+00:00\",\"dateModified\":\"2025-10-01T08:09:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/\"},\"wordCount\":262,\"publisher\":{\"@id\":\"https:\/\/chemicalsafety.com\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg\",\"articleSection\":[\"Non classifi\u00e9(e)\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/\",\"url\":\"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/\",\"name\":\"L'approbation am\u00e9ricaine d'urgence \u00e9largit l'utilisation du m\u00e9dicament COVID-19 de Gilead remdesivir\",\"isPartOf\":{\"@id\":\"https:\/\/chemicalsafety.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg\",\"datePublished\":\"2021-01-07T20:56:42+00:00\",\"dateModified\":\"2025-10-01T08:09:47+00:00\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/#primaryimage\",\"url\":\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg\",\"contentUrl\":\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg\",\"width\":750,\"height\":400,\"caption\":\"U.S. emergency approval broadens use of Gilead\u2019s COVID-19 drug remdesivir\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/chemicalsafety.com\/fr\/#website\",\"url\":\"https:\/\/chemicalsafety.com\/fr\/\",\"name\":\"ChemicalSafety\",\"description\":\"EH&amp;S Software\",\"publisher\":{\"@id\":\"https:\/\/chemicalsafety.com\/fr\/#organization\"},\"alternateName\":\"Chemical Safety Software\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/chemicalsafety.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/chemicalsafety.com\/fr\/#organization\",\"name\":\"ChemicalSafety\",\"alternateName\":\"Chemical Safety Software\",\"url\":\"https:\/\/chemicalsafety.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/chemicalsafety.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2018\/01\/logo4.png\",\"contentUrl\":\"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2018\/01\/logo4.png\",\"width\":100,\"height\":100,\"caption\":\"ChemicalSafety\"},\"image\":{\"@id\":\"https:\/\/chemicalsafety.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Chemical-Safety-Software-1391503304442241\/\",\"https:\/\/x.com\/chemsafeems\",\"https:\/\/www.linkedin.com\/company\/chemical-safety-software\/\",\"https:\/\/www.youtube.com\/channel\/UC3i_ZkwvVM2HnmO65fzFu4A\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/chemicalsafety.com\/fr\/#\/schema\/person\/9a6af7129d32d51cd09d6bbfbcb03336\",\"name\":\"Chemical Safety Software\",\"sameAs\":[\"http:\/\/chemicaldafety.com\"],\"url\":\"https:\/\/chemicalsafety.com\/fr\/author\/iokastik\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"L'approbation am\u00e9ricaine d'urgence \u00e9largit l'utilisation du m\u00e9dicament COVID-19 de Gilead remdesivir","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/","og_locale":"fr_FR","og_type":"article","og_title":"L'approbation am\u00e9ricaine d'urgence \u00e9largit l'utilisation du m\u00e9dicament COVID-19 de Gilead remdesivir","og_description":"En ces temps difficiles, les bonnes nouvelles sont toujours les bienvenues et doivent \u00eatre partag\u00e9es. Nous sommes honor\u00e9s et fiers d&rsquo;annoncer que Gilead Sciences, l&rsquo;un des clients les plus anciens et les plus importants de Chemical Safety Software, a re\u00e7u l&rsquo;approbation de la Food and Drug Administration (FDA) des \u00c9tats-Unis pour son traitement exp\u00e9rimental Covid-19 [&hellip;]","og_url":"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/","og_site_name":"ChemicalSafety","article_publisher":"https:\/\/www.facebook.com\/Chemical-Safety-Software-1391503304442241\/","article_published_time":"2021-01-07T20:56:42+00:00","article_modified_time":"2025-10-01T08:09:47+00:00","og_image":[{"width":750,"height":400,"url":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg","type":"image\/jpeg"}],"author":"Chemical Safety Software","twitter_card":"summary_large_image","twitter_creator":"@chemsafeems","twitter_site":"@chemsafeems","twitter_misc":{"\u00c9crit par":"Chemical Safety Software","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/#article","isPartOf":{"@id":"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/"},"author":{"name":"Chemical Safety Software","@id":"https:\/\/chemicalsafety.com\/fr\/#\/schema\/person\/9a6af7129d32d51cd09d6bbfbcb03336"},"headline":"L&rsquo;approbation am\u00e9ricaine d&rsquo;urgence \u00e9largit l&rsquo;utilisation du m\u00e9dicament COVID-19 de Gilead remdesivir","datePublished":"2021-01-07T20:56:42+00:00","dateModified":"2025-10-01T08:09:47+00:00","mainEntityOfPage":{"@id":"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/"},"wordCount":262,"publisher":{"@id":"https:\/\/chemicalsafety.com\/fr\/#organization"},"image":{"@id":"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/#primaryimage"},"thumbnailUrl":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg","articleSection":["Non classifi\u00e9(e)"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/","url":"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/","name":"L'approbation am\u00e9ricaine d'urgence \u00e9largit l'utilisation du m\u00e9dicament COVID-19 de Gilead remdesivir","isPartOf":{"@id":"https:\/\/chemicalsafety.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/#primaryimage"},"image":{"@id":"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/#primaryimage"},"thumbnailUrl":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg","datePublished":"2021-01-07T20:56:42+00:00","dateModified":"2025-10-01T08:09:47+00:00","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/chemicalsafety.com\/fr\/lapprobation-americaine-durgence-elargit-lutilisation-du-medicament-covid-19-de-gilead-remdesivir\/#primaryimage","url":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg","contentUrl":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2020\/05\/gileads-covid-19-drug-remdesivir-1.jpg","width":750,"height":400,"caption":"U.S. emergency approval broadens use of Gilead\u2019s COVID-19 drug remdesivir"},{"@type":"WebSite","@id":"https:\/\/chemicalsafety.com\/fr\/#website","url":"https:\/\/chemicalsafety.com\/fr\/","name":"ChemicalSafety","description":"EH&amp;S Software","publisher":{"@id":"https:\/\/chemicalsafety.com\/fr\/#organization"},"alternateName":"Chemical Safety Software","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/chemicalsafety.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/chemicalsafety.com\/fr\/#organization","name":"ChemicalSafety","alternateName":"Chemical Safety Software","url":"https:\/\/chemicalsafety.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/chemicalsafety.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2018\/01\/logo4.png","contentUrl":"https:\/\/chemicalsafety.com\/wp-content\/uploads\/2018\/01\/logo4.png","width":100,"height":100,"caption":"ChemicalSafety"},"image":{"@id":"https:\/\/chemicalsafety.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Chemical-Safety-Software-1391503304442241\/","https:\/\/x.com\/chemsafeems","https:\/\/www.linkedin.com\/company\/chemical-safety-software\/","https:\/\/www.youtube.com\/channel\/UC3i_ZkwvVM2HnmO65fzFu4A"]},{"@type":"Person","@id":"https:\/\/chemicalsafety.com\/fr\/#\/schema\/person\/9a6af7129d32d51cd09d6bbfbcb03336","name":"Chemical Safety Software","sameAs":["http:\/\/chemicaldafety.com"],"url":"https:\/\/chemicalsafety.com\/fr\/author\/iokastik\/"}]}},"_links":{"self":[{"href":"https:\/\/chemicalsafety.com\/fr\/wp-json\/wp\/v2\/posts\/71071","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/chemicalsafety.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/chemicalsafety.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/chemicalsafety.com\/fr\/wp-json\/wp\/v2\/users\/3590"}],"replies":[{"embeddable":true,"href":"https:\/\/chemicalsafety.com\/fr\/wp-json\/wp\/v2\/comments?post=71071"}],"version-history":[{"count":0,"href":"https:\/\/chemicalsafety.com\/fr\/wp-json\/wp\/v2\/posts\/71071\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/chemicalsafety.com\/fr\/wp-json\/wp\/v2\/media\/89592"}],"wp:attachment":[{"href":"https:\/\/chemicalsafety.com\/fr\/wp-json\/wp\/v2\/media?parent=71071"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/chemicalsafety.com\/fr\/wp-json\/wp\/v2\/categories?post=71071"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/chemicalsafety.com\/fr\/wp-json\/wp\/v2\/tags?post=71071"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}